PharmaCielo Ltd. is a global company headquartered in Canada and publicly traded on the TSXV under the ticker PCLO. We chose Canada to house our global parent based on its high standards of financial accountability and leadership in establishing a highly regulated, national medical cannabis industry.
PharmaCielo Colombia Holdings S.A.S., its wholly owned operating subsidiary, is headquartered in Rionegro, Colombia. We chose Colombia as our operational base for its outstanding climatic and economic conditions, including its history in the cut-flower industry, as well as its clear legal framework for cannabis licensing.
Together, these factors make Colombia the most cost-competitive and environmentally friendly nation for producing all natural cannabis products of the highest quality.
We’re the first company to hold Colombian licences for cannabis with unrestricted percentages of tetrahydrocannabinol (THC) and cannabidiol (CBD), making us the world’s largest licensed producer.
Our medicinal-grade oil extracts and related products provide reliable, standardized relief and wellness formulas for patients in need, including those requiring higher levels of THC.